Skip to main content
Erschienen in: Endocrine 3/2016

15.09.2016 | Original Article

Searching for the most effective thyrotropin (TSH) threshold to rule-out autonomously functioning thyroid nodules in iodine deficient regions

verfasst von: Luca Giovanella, Federica D’Aurizio, Alfredo Campenni’, Rosaria Maddalena Ruggeri, Sergio Baldari, Frederik Anton Verburg, Pierpaolo Trimboli, Luca Ceriani

Erschienen in: Endocrine | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study is to evaluate the distribution of thyrotropin (TSH) values in patients with autonomously functioning thyroid nodules and to set a TSH threshold above which thyroid scintigraphy would be obviated. Four hundred fifty one patients were included in the present study. Inclusion criteria were age > 18 years, TSH levels between 0.40 and 4.0 mIU/L, detection of a single solid or predominantly solid thyroid nodule >10 mm in the longest diameter. Thyroid ultrasound and thyroid scintigraphy with 99mTc-pertechnetate were performed concurrently in all patients. Among 451 enrolled patients, 173 (38 %) had an autonomously functioning thyroid nodules, of which 137 (79 %) with a normal TSH level. Demographic data and nodules’ volume were not significantly different in patients with autonomously functioning thyroid nodules and non-functioning nodules, respectively. However, TSH levels were nonetheless significantly lower in patients with autonomously functioning thyroid nodules compared to those with non-functioning nodules (p < 0.001). Adopting a TSH cutoff level at 2.38 mUI/L, all autonomously functioning thyroid nodules were correctly identified (i.e., 100 % sensitivity) with a 100 % negative predictive value. Our study showed a very high prevalence of autonomously functioning thyroid nodules in mildly iodine-deficient regions and confirmed that serum TSH is not an effective screening test to diagnose an autonomously functioning thyroid nodules. Our data add arguments in favor of the first-line use of thyroid scintigraphy to assess thyroid nodules, at least in iodine deficient areas. As all scintigraphically detected autonomously functioning thyroid nodules had a TSH level below 2.38 mUI/L, a thyroid scintigraphy should be omitted when higher TSH values are found in patients carrying a thyroid nodule.
Literatur
1.
Zurück zum Zitat L. Giovanella, L. Ceriani, G. Treglia, Role of isotope scan, including positron emission tomography/computed tomography, in nodular goitre. Best. Pract. Res. Clin. Endocrinol. Metab. 28, 507–518 (2014)CrossRefPubMed L. Giovanella, L. Ceriani, G. Treglia, Role of isotope scan, including positron emission tomography/computed tomography, in nodular goitre. Best. Pract. Res. Clin. Endocrinol. Metab. 28, 507–518 (2014)CrossRefPubMed
2.
Zurück zum Zitat H. Schicha, M. Hellmich, W. Lehmacher, W. Eschner, M. Schmidt, C. Kobe et al., Should all patients with thyroid nodules ≥ 1 cm undergo aspiration biopsy? Nuklearmedizin 48, 79–83 (2009)PubMed H. Schicha, M. Hellmich, W. Lehmacher, W. Eschner, M. Schmidt, C. Kobe et al., Should all patients with thyroid nodules ≥ 1 cm undergo aspiration biopsy? Nuklearmedizin 48, 79–83 (2009)PubMed
3.
Zurück zum Zitat B.R. Haugen, E.K. Alexander, K.C. Bible, J.M. Doherty, S.J. Mandel, Y.E. Nikiforov et al., 2015 American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016)CrossRefPubMed B.R. Haugen, E.K. Alexander, K.C. Bible, J.M. Doherty, S.J. Mandel, Y.E. Nikiforov et al., 2015 American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016)CrossRefPubMed
5.
Zurück zum Zitat R. Gorges, T. Kandror, S. Kuschnerus, M. Zimny, R. Pink, H. Palmedo et al., Scintigraphically “hot” thyroid nodules mainly go hand in hand with a normal TSH. Nuklearmedizin 50, 179–188 (2011)CrossRefPubMed R. Gorges, T. Kandror, S. Kuschnerus, M. Zimny, R. Pink, H. Palmedo et al., Scintigraphically “hot” thyroid nodules mainly go hand in hand with a normal TSH. Nuklearmedizin 50, 179–188 (2011)CrossRefPubMed
6.
Zurück zum Zitat D. Graf, B. Helmich-Kapp, S. Graf, F. Veit, N. Lehmann, K. Mann, Functional activity of autonomous adenoma in Germany. Dtsch. Med. Wochenschr. 137, 2089–2092 (2012)CrossRefPubMed D. Graf, B. Helmich-Kapp, S. Graf, F. Veit, N. Lehmann, K. Mann, Functional activity of autonomous adenoma in Germany. Dtsch. Med. Wochenschr. 137, 2089–2092 (2012)CrossRefPubMed
7.
Zurück zum Zitat D. Sandrock, T. Olbricht, D. Emrich, G. Benker, D. Reinwein, Longterm follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol. 128, 51–55 (1993)PubMed D. Sandrock, T. Olbricht, D. Emrich, G. Benker, D. Reinwein, Longterm follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol. 128, 51–55 (1993)PubMed
8.
Zurück zum Zitat R. Chami, R. Moreno-Reyes, B. Corvilain, TSH measurement is not an appropriate screening test for autonomous functioning thyroid nodules: a retrospective study of 368 patients. Eur. J. Endocrinol. 170, 593–599 (2014)CrossRefPubMed R. Chami, R. Moreno-Reyes, B. Corvilain, TSH measurement is not an appropriate screening test for autonomous functioning thyroid nodules: a retrospective study of 368 patients. Eur. J. Endocrinol. 170, 593–599 (2014)CrossRefPubMed
9.
Zurück zum Zitat G. Treglia, P. Trimboli, F.A. Verburg, M. Luster, L. Giovanella, Prevalence of normal TSH among patients with autonomously functioning thyroid nodules. Eur. J. Clin. Invest. 45, 739–744 (2015)CrossRefPubMed G. Treglia, P. Trimboli, F.A. Verburg, M. Luster, L. Giovanella, Prevalence of normal TSH among patients with autonomously functioning thyroid nodules. Eur. J. Clin. Invest. 45, 739–744 (2015)CrossRefPubMed
10.
Zurück zum Zitat M. Olivieri, P. Vitti, Attività di monitoraggio del programma nazionale per la prevenzione dei disordini da carenza iodica. http://www.iss.it/binary/osna/cont/Rapporto_Istisan_2014.pdf (2014). Accessed 6 August 2016 M. Olivieri, P. Vitti, Attività di monitoraggio del programma nazionale per la prevenzione dei disordini da carenza iodica. http://​www.​iss.​it/​binary/​osna/​cont/​Rapporto_​Istisan_​2014.​pdf (2014). Accessed 6 August 2016
11.
Zurück zum Zitat M. Anderson, B. de Benoist, I. Darrnton-Hill, F. Delalonge, Iodine deficiency in Europe. A continuing public health problem. http://www.who.int/nutrition/publications/VMNIS_Iodine_deficiency_in_Europe.pdf (2007). Accessed 6 August 2016 M. Anderson, B. de Benoist, I. Darrnton-Hill, F. Delalonge, Iodine deficiency in Europe. A continuing public health problem. http://​www.​who.​int/​nutrition/​publications/​VMNIS_​Iodine_​deficiency_​in_​Europe.​pdf (2007). Accessed 6 August 2016
12.
Zurück zum Zitat M. Heinisch, G. Kumnig, D. Asböck, P. Mikosch, H.J. Gallowitsch, E. Kresnik et al., Goiter prevalence and iodine urinary excretion in a formerly iodine deficient region after introduction of statutory iodization of common salt. Thyroid 12, 809–814 (2002)CrossRefPubMed M. Heinisch, G. Kumnig, D. Asböck, P. Mikosch, H.J. Gallowitsch, E. Kresnik et al., Goiter prevalence and iodine urinary excretion in a formerly iodine deficient region after introduction of statutory iodization of common salt. Thyroid 12, 809–814 (2002)CrossRefPubMed
13.
Zurück zum Zitat A.C. van de Ven, R.T. Netea-Maier, H.A. Ross, T.A. van Herwaarden, S. Holewijn, J. de Graaf et al., Longitudinal trends in thyroid function in relation to iodine intake: ongoing changes of thyroid function despite adequate current iodine status. Eur. J. Endocrinol. 170, 49–54 (2013)PubMed A.C. van de Ven, R.T. Netea-Maier, H.A. Ross, T.A. van Herwaarden, S. Holewijn, J. de Graaf et al., Longitudinal trends in thyroid function in relation to iodine intake: ongoing changes of thyroid function despite adequate current iodine status. Eur. J. Endocrinol. 170, 49–54 (2013)PubMed
14.
Zurück zum Zitat J.I. Hamburger, The autonomously functioning thyroid nodule: Goetsch’s disease. Endocrine Reviews 8, 439–447 (1998)CrossRef J.I. Hamburger, The autonomously functioning thyroid nodule: Goetsch’s disease. Endocrine Reviews 8, 439–447 (1998)CrossRef
15.
Zurück zum Zitat L. Hegedus, S.J. Bonnema, F.N. Bennedbaek, Management of simple nodular goiter: current status and future perspectives. Endocr. Rev. 24, 102–132 (2003)CrossRefPubMed L. Hegedus, S.J. Bonnema, F.N. Bennedbaek, Management of simple nodular goiter: current status and future perspectives. Endocr. Rev. 24, 102–132 (2003)CrossRefPubMed
16.
Zurück zum Zitat P. Andermann, S. Schlögl, U. Mäder, M. Luster, M. Lassmann, C. Reiners, Intra- and interobserver variability of thyroid volume measurements in healthy adults by 2D versus 3D ultrasound. Nuklearmedizin 46, 1–7 (2007)PubMed P. Andermann, S. Schlögl, U. Mäder, M. Luster, M. Lassmann, C. Reiners, Intra- and interobserver variability of thyroid volume measurements in healthy adults by 2D versus 3D ultrasound. Nuklearmedizin 46, 1–7 (2007)PubMed
17.
Zurück zum Zitat P. Laurberg, S. Andersen, A. Carlé, J. Karmisholt, N. Knudsen, I.B. Pedersen, The TSH upper reference limit: where are we at? Nat. Rev. Endocrinol. 7, 232–239 (2011)CrossRefPubMed P. Laurberg, S. Andersen, A. Carlé, J. Karmisholt, N. Knudsen, I.B. Pedersen, The TSH upper reference limit: where are we at? Nat. Rev. Endocrinol. 7, 232–239 (2011)CrossRefPubMed
18.
Zurück zum Zitat M.I. Surks, J.G. Hollowell, Age-specific distribution of serum thyrotropin and antithyroid antibobides in the US population: implications for the prevalence of subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 92, 4575–4582 (2007)CrossRefPubMed M.I. Surks, J.G. Hollowell, Age-specific distribution of serum thyrotropin and antithyroid antibobides in the US population: implications for the prevalence of subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 92, 4575–4582 (2007)CrossRefPubMed
19.
Zurück zum Zitat B. Biondi, Thyroid and obesity: an intriguing relationship. J. Clin. Endocrinol. Metab. 95, 3614–3617 (2010)CrossRefPubMed B. Biondi, Thyroid and obesity: an intriguing relationship. J. Clin. Endocrinol. Metab. 95, 3614–3617 (2010)CrossRefPubMed
20.
Zurück zum Zitat J.G. Hollowell, N.W. Stehling, W.E. Flanders, Serum TSH, T4, and anthyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002)CrossRefPubMed J.G. Hollowell, N.W. Stehling, W.E. Flanders, Serum TSH, T4, and anthyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002)CrossRefPubMed
21.
Zurück zum Zitat L. DeGroot, M. Abalovich, E.K. Alexander, Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J. Clin Endocrinol. Metab. 97, 2543–2565 (2012)CrossRef L. DeGroot, M. Abalovich, E.K. Alexander, Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J. Clin Endocrinol. Metab. 97, 2543–2565 (2012)CrossRef
22.
Zurück zum Zitat Kopp, P., Thyrotoxicosis of other ethiologies. In: De Groot L.J. (ed.) Endotext, http://www.thyroidmanager.org/chapter/thyrotoxicosis-of-other-etiologies/ (2000). Accessed 6 August 2016 Kopp, P., Thyrotoxicosis of other ethiologies. In: De Groot L.J. (ed.) Endotext, http://​www.​thyroidmanager.​org/​chapter/​thyrotoxicosis-of-other-etiologies/​ (2000). Accessed 6 August 2016
23.
Zurück zum Zitat J. Ehrenkranz, P.R. Bach, G.L. Snow, A. Schneider, J.L. Lee, S. Ilstrup, S.T. Bennett, S. Benvenga, Circadian and circannual rhythms in thyroid hormones: determining the TSH and free T4 reference intervals based upon time of day, age, and sex. Thyroid 25, 954–961 (2015)CrossRefPubMed J. Ehrenkranz, P.R. Bach, G.L. Snow, A. Schneider, J.L. Lee, S. Ilstrup, S.T. Bennett, S. Benvenga, Circadian and circannual rhythms in thyroid hormones: determining the TSH and free T4 reference intervals based upon time of day, age, and sex. Thyroid 25, 954–961 (2015)CrossRefPubMed
24.
Zurück zum Zitat M. Plebani, Biochemical and imaging biomarkers: the search for the Holy Grail. Clin. Chem. Lab. Med. 48, 1055–1056 (2010)PubMed M. Plebani, Biochemical and imaging biomarkers: the search for the Holy Grail. Clin. Chem. Lab. Med. 48, 1055–1056 (2010)PubMed
25.
Zurück zum Zitat B.C. Ahn, Personalized medicine based on theranostic radioiodine molecular imaging for differentiated thyroid cancer. Biomed. Res. Int. 2016, 9(2016). doi: 10.1155/2016/1680464 B.C. Ahn, Personalized medicine based on theranostic radioiodine molecular imaging for differentiated thyroid cancer. Biomed. Res. Int. 2016, 9(2016). doi: 10.​1155/​2016/​1680464
26.
Zurück zum Zitat G. Ronga, M. Filesi, R. D’Apollo, M. Toteda, A.D. Di Nicola, M. Colandrea et al., Autonomous functioning thyroid nodules and 131I in diagnosis and therapy after 50 years of experience: what is still open to debate? Clin. Nucl. Med. 38, 349–353 (2013)CrossRefPubMed G. Ronga, M. Filesi, R. D’Apollo, M. Toteda, A.D. Di Nicola, M. Colandrea et al., Autonomous functioning thyroid nodules and 131I in diagnosis and therapy after 50 years of experience: what is still open to debate? Clin. Nucl. Med. 38, 349–353 (2013)CrossRefPubMed
27.
Zurück zum Zitat G. Beckett, F. MacKenzie, Thyroid guidelines – are thyroid-stimulating hormone assays fit for purpose? Ann. Clin. Biochem. 44, 203–208 (2007)CrossRefPubMed G. Beckett, F. MacKenzie, Thyroid guidelines – are thyroid-stimulating hormone assays fit for purpose? Ann. Clin. Biochem. 44, 203–208 (2007)CrossRefPubMed
Metadaten
Titel
Searching for the most effective thyrotropin (TSH) threshold to rule-out autonomously functioning thyroid nodules in iodine deficient regions
verfasst von
Luca Giovanella
Federica D’Aurizio
Alfredo Campenni’
Rosaria Maddalena Ruggeri
Sergio Baldari
Frederik Anton Verburg
Pierpaolo Trimboli
Luca Ceriani
Publikationsdatum
15.09.2016
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2016
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1094-3

Weitere Artikel der Ausgabe 3/2016

Endocrine 3/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.